Cambridge, MA, United States of America

Andreas Raue

This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignees: Albert-Ludwigs-Universitat Freiburg, Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts. Active years: 2020.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Anemia Treatment by Andreas Raue

Introduction

Andreas Raue is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of anemia. His innovative approach focuses on optimizing dosage regimens for erythropoiesis stimulating agents (ESA) in patients suffering from anemia, especially those with cancer.

Latest Patents

Raue holds a patent for "Methods for the prediction of a personalized ESA-dose in the treatment of anemia." This invention features an integrative pharmacokinetic/pharmacodynamics (PK/PD) mathematical model that calculates the binding behavior of ESAs. The model allows clinical practitioners to determine ESA binding sites in patients, enabling them to optimize treatment dosages effectively. This is particularly crucial for patients with cancer, as the invention also includes methods for screening ESAs that specifically target cells expressing high levels of the EPO receptor.

Career Highlights

Throughout his career, Raue has worked with notable institutions, including the Deutsches Krebsforschungszentrum and Albert-Ludwigs-Universität Freiburg. His work has been instrumental in advancing the understanding of anemia treatment and improving patient outcomes.

Collaborations

Raue has collaborated with esteemed colleagues such as Ursula Klingmueller and Jens Timmer. Their combined expertise has contributed to the development of innovative solutions in the medical field.

Conclusion

Andreas Raue's contributions to anemia treatment through his patented methods demonstrate the importance of innovation in healthcare. His work not only enhances the understanding of ESA binding but also paves the way for more effective treatment strategies for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…